Association of ANRIL polymorphism (rs1333049: C>G) with myocardial infarction and its pharmacogenomic role in hypercholesterolemia

Gene

Volumn 515, Issue 2, 2013, Pages 416-420

  Ahmed, Waqas ^a   Ali, Imran Saeed ^b   Riaz, Moeen ^a   Younas, Asma ^c   Sadeque, Ahmed ^a   Niazi, Asfandyar Khan ^d   Niazi, Saad Hameed ^d   Ali, Syeda Hafiza Benish ^a,e   Azam, Maleeha ^a   Qamar, Raheel ^a,d  

^a Department of Electrical Computer Engineering   (Pakistan)

^b Rawalpindi Institute of Cardiology   (Pakistan)

^c Benazir Bhutto Hospital   (Pakistan)

^d SHIFA COLLEGE OF MEDICINE   (Pakistan)

^e BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

Author keywords

ANRIL polymorphism; Coronary artery diseases; Genetics; Myocardial infarction

Indexed keywords

ANRIL PROTEIN; CHOLESTEROL; CYSTEINE; GLYCINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE FREQUENCY; GENOTYPE; HEART INFARCTION; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PHARMACOGENOMICS; PLEIOTROPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANTICHOLESTEREMIC AGENTS; CASE-CONTROL STUDIES; CHOLESTEROL; DRUG RESISTANCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PAKISTAN; POLYMORPHISM, SINGLE NUCLEOTIDE; PYRROLES; RISK; RNA, LONG UNTRANSLATED; SEQUENCE ANALYSIS, DNA; TRIGLYCERIDES;

EID: 84872500320     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.12.044     Document Type: Article

References (24)

1. Ajmal M., et al. A novel pathogenic nonsense triple-nucleotide mutation in the low-density lipoprotein receptor gene and its clinical correlation with familial hypercholesterolemia. Genet. Test. Mol. Biomarkers 2011, 15:601-606.
2. Baudhuin L.M. Genetics of coronary artery disease: focus on genome-wide association studies. Am. J. Transl. Res. 2009, 1:221-234.
3. Cheng X., et al. The same chromosome 9p21.3 locus is associated with type 2 diabetes and coronary artery disease in a Chinese Han population. Diabetes 2011, 60:680-684.
4. Cunnington M.S., Santibanez K.M., Mayosi B.M., Burn J., Keavney B. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet. 2010, 6:e1000899.
5. deWerf V.F., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur. Heart J. 2008, 29:2909-2945.
6. Ding H., et al. 9p21 is a shared susceptibility locus strongly for coronary artery disease and weakly for ischemic stroke in Chinese Han population. Circ. Cardiovasc. Genet. 2009, 2:338-346.
7. Farzaneh-Far R., Na B., Schiller N.B., Whooley M.A. Lack of association of chromosome 9p21.3 genotype with cardiovascular structure and function in persons with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009, 205:492-496.
8. Helgadottir A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316:1491-1493.
9. Holdt L.M., et al. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler. Thromb. Vasc. Biol. 2010, 30:620-627.
10. Jarinova O., et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1671-1677.
11. Laurent G., Faghihi M.A., Wahlestedt C. Non-coding RNA transcripts: sensors of neuronal stress, modulators of synaptic plasticity and agents of change in the onset of Alzheimer's disease. Neurosci. Lett. 2009, 466:81-88.
12. Little S. Amplification-refractory mutation system (ARMS) analysis of point mutations. Current Protocols in Human Genetics 2001, 9.8.1-9.8.12. John Wiley & Sons, New York. A.L. Boyle (Ed.).
13. Liu J., Gough J., Rost B. Distinguishing protein-coding from non-coding RNAs through support vector machines. PLoS Genet. 2006, 2:e29.
14. Marks D., Thorogood M., Neil H.A., Humphries S.E. A review on the diagnosis, natural history, and treatment of familial hypercholesterolemia. Atherosclerosis 2003, 168:1-14.
15. McPherson R. Chromosome 9p21 and coronary artery disease. N. Engl. J. Med. 2010, 362:1736-1737.
16. McPherson R., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316:1488-1491.
17. Mondal T., Rasmussen M., Pandey G.K., Isaksson A., Kanduri C. Characterization of the RNA content of chromatin. Genome Res. 2010, 20:899-907.
18. Saleheen D., et al. Association of the 9p21.3 locus with risk of first-ever myocardial infarction in Pakistanis: case-control study in South Asia and updated meta-analysis of Europeans. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1467-1473.
19. Samani N.J., Schunkert H. Chromosome 9p21 and cardiovascular disease: the story unfolds. Circ. Cardiovasc. Genet. 2008, 1:81-84.
20. Vickers K.C., Remaley A.T. MicroRNAs in atherosclerosis and lipoprotein metabolism. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17:150-155.
21. Vickers K.C., Palmisano B.T., Remaley A.T. The role of noncoding "junk DNA" in cardiovascular disease. Clin. Chem. 2010, 56:1518-1520.
22. Visel A., et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010, 464:409-412.
23. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
24. Zeggini E., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.